Back to search
FDAFDA · Food and drugs·Recall number D-0947-2018

HEPARIN 12,500 Units in 5% Dextrose. (Heparin Sodium, USP 12,500 Units, 5% Dextrose Inj., USP 250 mL) Volume: 252.5 mL. Single dose bag. Avella Specialty Pharmacy, 24416 N 19th Avenue Phoenix, AZ 85085. NDC 42852-745-25

Published July 25, 2018 · Recall initiated: June 12, 2018

Summary

FDA records drug Class II recall D-0947-2018, published July 25, 2018 and initiated June 12, 2018. Recalling firm: Avella of Deer Valley, Inc. Store 38; Status: Terminated; Reported quantity: 900 bags; Lot: Lot #: 138-20181105@65,138-20181105@64, 138-20181105@63, BUD 8/19/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Potential leakage of bags.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Avella of Deer Valley, Inc. Store 38
Distributor
Nationwide in the USA
Lot
Lot #: 138-20181105@65,138-20181105@64, 138-20181105@63, BUD 8/19/2018.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was HEPARIN 12,500 Units in 5% Dextrose. (Heparin Sodium, USP 12,500 Units, 5% Dextrose Inj., USP 250 mL) Volume: 252.5 mL. Single dose bag. Avella Specialty Pharmacy, 24416 N 19th Avenue Phoenix, AZ 85085. NDC 42852-745-25 recalled?

Yes. FDA published recall D-0947-2018 on July 25, 2018. Reported hazard: Lack of Assurance of Sterility: Potential leakage of bags.

What should I do if I have this product?

Voluntary: Firm initiated · Letter